Clinical Trials Directory

Trials / Completed

CompletedNCT01712373

Ginseng in Treatment of Fatigue in Multiple Sclerosis

Study of Ginseng in Treatment of Fatigue in Multiple Sclerosis

Status
Completed
Phase
Phase 2
Study type
Interventional
Enrollment
60 (actual)
Sponsor
Isfahan University of Medical Sciences · Academic / Other
Sex
All
Age
18 Years – 50 Years
Healthy volunteers
Accepted

Summary

The purpose of this study was to evaluate the efficacy and safety of Ginseng in treatment of fatigue and Quality of Life of MS patients.

Detailed description

Multiple Sclerosis (MS) is one of the most common non-traumatic causes of disability in the world. It is a chronic inflammatory and demyelinating disorder of the Central Nervous System (CNS) which affects individuals in the productive ages and causes a large burden for years to come. Fatigue is a common complaint and one of the least understood symptoms of MS

Conditions

Interventions

TypeNameDescription
DRUGGinsengit is kind of drug
DRUGPlaceboit is placebo

Timeline

Start date
2010-12-01
Primary completion
2011-04-01
Completion
2011-04-01
First posted
2012-10-23
Last updated
2012-10-23

Locations

1 site across 1 country: Iran

Source: ClinicalTrials.gov record NCT01712373. Inclusion in this directory is not an endorsement.